Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms

Pharmacology, Toxicology and Pharmaceutical Science

• Nitric Oxide 100%
• Nitric Oxide Donor 100%
• Cyclic GMP 100%
• Diethylamine 60%
• Nitroprusside Sodium 40%
• S-Nitrosothiol 40%
• Glyceryl Trinitrate 40%
• Adenosine Diphosphate 20%
• Peroxynitrite 20%
• Guanylate Cyclase 20%
• 1h 1,2,4 oxadiazolo[4,3 A]quinoxalin 1 One 20%
• Guanylate Cyclase Inhibitor 20%
• S Nitrosoglutathione 20%
• Nitrosonium 20%

Biochemistry, Genetics and Molecular Biology

• Nitric Oxide 100%
• Cyclic Guanosine Monophosphate 100%
• Thrombocyte Aggregation 100%
• S-Nitrosothiol 25%
• Platelet-Rich Plasma 12%
• S-Nitrosoglutathione 12%
• Agonist 12%
• Mediator 12%
• Guanylate Cyclase 12%
• Thrombocyte Activation 12%
• Adenosine Diphosphate 12%

Neuroscience

• Thrombocyte Aggregation 100%
• Nitric Oxide 100%
• Cyclic Guanosine Monophosphate 100%
• Platelet 25%
• Sodium Nitroprusside 25%
• Adenosine Diphosphate 12%
• Guanylate Cyclase 12%
• Blood Plasma 12%
• Agonist 12%
• S Nitrosoglutathione 12%